The Course of Treatment

Cancer and the immune system are undergoing dynamic processes that have to be taken into account during treatment. Therefore, the IOZK-Immunotherapy is individually tailored for each patient. Thanks to its favorable tolerability, it can be performed entirely on an outpatient basis.

The IOZK-Immunotherapy can be coordinated with other therapies such as surgery, radiation or chemotherapy, if necessary. Unlike chemotherapy or radiation, which follow a fixed timetable and pattern, IOZK-Immunotherapy is adjusted to the individual circumstances of the patient. It is continually adapted to possible modifications of the tumor and the immune system during the course of treatment.
Cancer is a chronic disease and may, under certain circumstances, recur even after successful therapy. Therefore, it is recommended to monitor the effectiveness of the immunotherapy at certain intervals. The exact course and duration of IOZK-Immunotherapy vary greatly because they depend on the type and course of the tumor disease as well as on the individual immunological response of each patient. The first step on the way to your individual immunotherapy is the initial consultation.

The initial appointment at the IOZK serves to take the medical history, review all diagnostic findings, and discuss both conventional and possible immunological treatment options. This is followed by blood sampling to analyze the immune system and tumor activity, the results of which are available after about two weeks.

The team of experts meets for an internal tumor conference and discusses the results, taking into account the patient’s medical history, and develops an individual therapeutic strategy.
This combines specially selected modules of the IOZK -Immunotherapy.

The recommendations of the tumor conference are then discussed with the patient. The individual therapy is planned taking into account the patient’s requirements and preferences.